The University of Cambridge has launched a major new initiative designed to accelerate the pace of innovation in interventions for clinically depressed mood.

The Mental Health Catalyst, led by the Institute for Manufacturing (IfM) through its knowledge-transfer company, IfM Engage, aims to bring together researchers, innovators, funders, policymakers, and people with lived experience to identify and prioritise new opportunities to address clinically depressed mood, and help people to get better and stay well.

Supported by Wellcome, the programme will apply innovation management and systems approaches developed at Cambridge to support the translation of mental health research into practical interventions that can be implemented at scale to improve outcomes.

Depression affects hundreds of millions of people worldwide and has profound individual, social and economic impacts. Although research has greatly expanded understanding of the condition, many people still face long delays before receiving effective treatment, existing interventions do not work for everyone, and relapse is common.

The Mental Health Catalyst aims to address this challenge by identifying high-potential intervention opportunities and supporting their development and implementation at scale. The programme’s mission is to make clinically depressed mood a short-lasting condition that does not affect lives in the longer term. The Catalyst will pursue this through the development of more effective, faster-acting and longer-lasting interventions that can be implemented sustainably at scale.

Connecting research, innovation and real-world impact

The initiative will synthesise evidence from across the social, psychological and biological sciences to better understand the drivers of depressed mood and identify strategic opportunities for intervention. These opportunities may include pharmaceutical, digital and other non-pharmaceutical approaches to improving the management and treatment of depressed mood.

The programme will also develop a “Mission Map” to help inform and coordinate research, innovation and investment across the mental health ecosystem. By bringing together stakeholders from research, healthcare, innovation and policy, the Catalyst aims to accelerate progress towards more effective interventions.

“Mental health research has generated an enormous amount of valuable knowledge, but translating that knowledge into effective interventions remains a major challenge," said Peter Templeton, Project Director of the Mental Health Catalyst at IfM Engage.  "The Mental Health Catalyst will bring together evidence, innovation and implementation in a structured way that helps the global mental health community identify and accelerate the most promising opportunities for impact.”

Peter B. Jones, Department of Psychiatry, University of Cambridge, added: “Research has greatly improved our understanding of the social, psychological and biological factors that contribute to depressed mood. The Mental Health Catalyst provides an important opportunity to translate that knowledge into innovative interventions that can improve outcomes for people affected by depressed mood.”

Building on 7 years of work

The initiative builds on 7 years of collaboration between the University of Cambridge’s Institute for Manufacturing and partners in mental health research and practice.

During this time, the IfM and IfM Engage have applied innovation management and systems engineering approaches to help translate research on the bio-psycho-social drivers of depression into practical intervention opportunities. Working with researchers, clinicians, charities and people with lived experience, the team has adapted methods such as evidence synthesis, root cause analysis and innovation roadmapping to identify promising opportunities for improving mental health outcomes.

This work has led to the development of a structured methodology – Understand : Innovate : Implement – which integrates evidence synthesis to understand the drivers of depressed mood, systematic identification and prioritisation of intervention opportunities, and coordinated approaches for developing, validating and implementing effective interventions at scale. The Mental Health Catalyst will apply this methodology to guide its work.

Tim Minshall, Dr John C Taylor Professor of Innovation and Head of the IfM, said: “Addressing depressed mood requires not only new scientific insights but also structured approaches for identifying and prioritising the most promising opportunities for intervention. At the IfM we have developed innovation management methods – including ideation, opportunity–feasibility prioritisation, roadmapping, ecosystem mapping delivered as facilitated stakeholder workshops – that help translate complex evidence into coordinated action. Applying these approaches within the Mental Health Catalyst will help accelerate interventions with the greatest potential for real-world impact.”

A global collaboration

The Mental Health Catalyst will be delivered in collaboration with international partners in mental health research, evidence synthesis, lived experience and other stakeholders across high-, low- and middle-income countries.

Over the coming months, the programme will convene a Steering Committee, Expert Advisory Panels and a Lived Experience Advisory Panel to guide the work and ensure that it reflects the priorities and experiences of people affected by depressed mood.

Researchers, innovators, funders, clinicians and policymakers will also be invited to participate in collaborative workshops and roadmapping activities to identify and develop new interventions.

Max Ahmed, Head of Mental Health Innovation at Wellcome, concluded: “We urgently need more effective, faster-acting and long-lasting ways to intervene early in depressed mood. Too often, promising research does not translate into interventions that reach people at scale.  Initiatives like the Mental Health Catalyst are critical because they bring together expertise across research, innovation and implementation to identify and accelerate the most promising opportunities for impact.”

The first phase of the initiative, Catalyst 1.0, will generate the initial Mission Map and identify high-priority intervention opportunities. The team is seeking additional partners and funders interested in contributing to future phases of the Catalyst that will support the development and scaling of promising interventions, and the systems needed to deliver them.

Get involved

The first phase of the initiative, Catalyst 1.0, will generate the initial Mission Map and identify high-priority intervention opportunities.

The team is seeking additional partners and funders interested in contributing to future phases of the Catalyst that will support the development and scaling of promising interventions and the systems needed to deliver them.

Researchers, innovators, healthcare professionals and strategists, funders, policymakers and individuals with lived experience who are interested in contributing to the programme are invited to engage with the Mental Health Catalyst.

Further information is available here.